Top Markets
Coin of the day
IPROMOMED IPROMOMED

IPROMOMED

PRMD
Rank in Stocks #9277
Operating out of Russia, iPROMOMED functions as a pharmaceutical and... Operating out of Russia, iPROMOMED functions as a pharmaceutical and biotechnology enterprise dedicated to the research, production, and commercialization of both traditional prescription medications and cutting-edge therapeutic solutions.
Share Price
$4.93
Last synced: 2026-08-28
Market Cap
$1.05B
Change (1 day)
1.36%
Change (1 year)
-9.02%
Country
RU
Trade IPROMOMED (PRMD)

Category

P/E ratio for IPROMOMED (PRMD)
P/E ratio as of 2026 TTM: 0
According to IPROMOMED latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for IPROMOMED from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.